The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.

LA SAL, Utah (KUTV) — The Federal Emergency Management Agency authorized the use of federal funds to help with the costs of ...

CEO of Iranian Engineering Company was Arrested for Allegedly Shipping Sophisticated Electronics to Iran in Violation of U.S. Sanctions ...

After two years of trying, Lisa Picho finally got the call to work at the San Jose Animal Care Center. She was thrilled to start as an animal care attendant in March. But she quickly felt ill-equipped ...

Children, the elderly and anyone with heart or lung conditions should reduce or avoid exertion and heavy work outdoors ...

On July 8, the US Supreme Court allowed President Trump’s executive order (EO) permitting Department of Government Efficiency (DOGE)-related planning efforts for the Trump Administration’s ...

DALLAS–FORT WORTH, TX / ACCESS Newswire / July 14, 2025 / ABC Plumbing, a trusted family-owned company with over three ...

DALLAS, TEXAS / ACCESS Newswire / July 14, 2025 / Welborn Garage, a trusted provider of garage and overhead door services ...

NJBIZ spotlights under-recognized health care leaders, from startup founders to behind-the-scenes pros driving innovation.

The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.